Fitch Solutions

Fitch Solutions provides crucial intelligence to help its clients understand and interpret markets, so they can protect their organisations’ interests and help to grow profitability.

India locally develops 35 previously imported pharma ingredients

The country is expected to remain keen to lessen pharma import dependency.

India locally develops 35 previously imported pharma ingredients

The country is expected to remain keen to lessen pharma import dependency.

Australia expands digital initiatives in COVID-19 response

The country’s pandemic landscape is expected to transform further in the coming months.

Digital healthcare demand to rise in India: report

The structural shift in the country’s healthcare system has been influenced by tech.

New Zealand’s medicines budget to boost R&D-based drugmakers

But Fitch Solutions’ report noted that allocation for medicine investment remains low.

Rise in Indian medicine exports may cause patent woes in Australia: Fitch

India's weak IP laws could be an issue for drug manufacturers in Australia.

Malaysian health expenditure to reach MYR91.1b in 2025: Fitch

The 2021 healthcare budget allocation is at MYR31.9b.

Vaccination in Asia slows as it faces supply constraints

In Asia, only 24.43% of the population have been fully vaccinated.

Chart of the Day: SG healthcare spending to reach $45.9b in 2030

Fitch Solutions expects the government to ramp up its healthcare expenditure in the coming years.

Pharmaceutical sales in China to reach CNY1.8t by 2030: Fitch

It is expected to grow at a CAGR of 5.7% over a ten-year forecast period. 

Slowing economy to affect Japan’s pharmaceuticals spending: Fitch

It also said that the annual medicine price review will affect medicine’s market growth trajectory. 

Medical device market in India expected to grow on the back of reforms, infrastructure: Fitch

Fitch said diagnostic imaging and patient aids will grow at a 2020-2025 CAGR of 10.7% and 11.2% in USD terms.

Indonesia hikes healthcare spending by 8% to $12.84b

The country’s healthcare system remained unprepared to deal with the virus surge.

Philippines mulls drug price cuts for foreign pharma

This is expected to affect local pharma growth in the short term.